Skip to main content
. 2021 Mar 9;2021(3):CD013522. doi: 10.1002/14651858.CD013522.pub2

Munafò 2008.

Study characteristics
Methods Study design: longitudinal cohort
Country: UK
Data collection period: 1991 ‐ 1995
Registry ID: N/A (cohort)
Participants Number of participants: N = 7089; Number included in meta‐analysis: N = 991
Sample characteristics (at baseline):
Age (mean): at birth 29 years (IQR 26 – 32); Sex (% male): 0% (0/7089)
Population category: pregnant population; Specific population: pregnant women
Nicotine dependence: not reported; Baseline cigarettes per day: not reported; Motivation to quit: not selected by motivation to quit
Interventions Behavioural support for smoking cessation: no behavioural support
Pharmacological support for smoking cessation: no pharmacological support
Psychotherapeutic or psychoactive support for mental health or mood: did not receive mood management
Outcomes Definition of cessation used: point prevalence (exact definitions not provided)
Cessation definition used for outcome(s) in this analysis: unclear point prevalence
Measure of biovalidation: not bioverified
Definition of people who continued smoking used: people who temporarily quit or who continued to smoke (exact definitions not provided)
Time point(s) at which follow‐up was conducted: assessments of current smoking asked at 6 intervals – 18 weeks and 32 weeks antenatal; 8 weeks, 8, 21 and 33 months postnatal
Outcome category: Depression
Outcome measure(s): Edinburgh Postnatal Depression Scale (EPDS)
Funding source The UK Medical Research Council, the Wellcome Trust, and the University of Bristol provided core support for this cohort study
Author conflicts of interest None specified
Notes Outcome data source: Published data